Soluble immune markers in the different phases of chronic hepatitis B virus infection

Chronic hepatitis B virus (HBV) infection may follow four different consecutive phases, which are defined by virology as well as biochemical markers and differ in terms of prognosis and need for antiviral treatment. Currently, host responses reflected by immune markers are not considered in this def...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiegand, Steffen B., Beggel, Bastian, Wranke, Anika, Aliabadi, Elmira, Jaroszewicz, Jerzy, Xu, Cheng-Jian, Li, Yang, Manns, Michael P., Lengauer, Thomas, Wedemeyer, Heiner, Kraft, Anke R. M., Falk, Christine S., Cornberg, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773856/
https://www.ncbi.nlm.nih.gov/pubmed/31575964
http://dx.doi.org/10.1038/s41598-019-50729-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773856/
https://www.ncbi.nlm.nih.gov/pubmed/31575964
http://dx.doi.org/10.1038/s41598-019-50729-5

Ejemplares similares